March 21, 2018 / 7:09 AM / a month ago

BRIEF-Sobi launches Ravicti in Europe ‍​

March 21 (Reuters) - Swedish Orphan Biovitrum:

* SAYS LAUNCHES RAVICTI IN EUROPE AND ADVANCES THE CARE FOR PATIENTS WITH UREA CYCLE DISORDERS

* SAYS HAS GAINED REIMBURSEMENT FOR RAVICTI®, A NEW THERAPY OPTION FOR THE TREATMENT OF PATIENTS WITH UREA CYCLE DISORDERS (UCDS) IN SEVERAL EU MEMBER STATES AND EEA-COUNTRIES

* SAYS SWEDEN, DENMARK, AUSTRIA AND GERMANY ARE THE FIRST COUNTRIES TO LAUNCH, FOLLOWED BY UK, SPAIN AND THE NETHERLANDS.‍​ Source text for Eikon: Further company coverage: (Stockholm Newsroom)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below